Nancy Miller-Rich

Ms. Nancy Miller-Rich is an Independent Director at 4D Molecular Therapeutics, Inc., an Independent Director at Attralus, Inc., an Independent Director at Aldeyra Therapeutics, Inc., a Chief Executive Officer at Miller-Rich Associates LLC and an Executive Chairman at MedMelior, Inc. She is on the Board of Directors at 4D Molecular Therapeutics, Inc., Attralus, Inc., Aldeyra Therapeutics, Inc., Global Alliance for TB Drug Development and Helio Vision, Inc. Ms. Miller-Rich was previously employed as a Chairman by BioTheryX, Inc., an Independent Director by Kadmon Holdings, Inc., a Co-Founder by Ten63 Therapeutics, Inc., an Independent Director by Intercept Pharmaceuticals, Inc., an Independent Non-Executive Director by UDG Healthcare Ltd. (Dublin), a SVP-Global Human Health Business Development by Merck & Co., Inc., and a SVP-Global Human Health Business Development by Schering-Plough Corp.
She received her undergraduate degree from Ithaca College.